BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28554336)

  • 1. Assessing immune competence in pigs by immunization with tetanus toxoid.
    Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M
    Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses of Asian elephants (Elephas maximus) to commercial tetanus toxoid vaccine.
    Lindsay WA; Wiedner E; Isaza R; Townsend HG; Boleslawski M; Lunn DP
    Vet Immunol Immunopathol; 2010 Feb; 133(2-4):287-9. PubMed ID: 19720403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals.
    Dieye TN; Sow PS; Simonart T; Guèye-Ndiaye A; Popper SJ; Delforge ML; Dieye A; Sarr AD; Crusiaux A; Van Vooren JP; Devleeschouwer M; Kanki P; Mboup S; Diakhate L; Farber CM
    Vaccine; 2001 Dec; 20(5-6):905-13. PubMed ID: 11738756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.
    Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Merino JM; Moro M; Navarro ML; Espín J; Omeñaca F; García-Sicilia J; Moreno-Pérez D; Ruiz-Contreras J; Centeno F; Barrio F; Cabanillas L; Muro M; Esporrin C; De Torres MJ; Caubet M; Boutriau D; Miller JM; Mesaros N
    Pediatr Infect Dis J; 2012 Oct; 31(10):1074-7. PubMed ID: 22828645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H; Gale RP; Saxon A
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune status and booster effects of low doses of tetanus toxoid in Swedish medical personnel.
    Björkholm B; Wahl M; Granström M; Hagberg L
    Scand J Infect Dis; 1994; 26(4):471-5. PubMed ID: 7984981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
    van Ravenhorst MB; Marinovic AB; van der Klis FR; van Rooijen DM; van Maurik M; Stoof SP; Sanders EA; Berbers GA
    Vaccine; 2016 Dec; 34(50):6309-6315. PubMed ID: 27817957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to tetanus booster in infants aged 15 months born prematurely with very low birth weight.
    Perin MC; Schlindwein CF; de Moraes-Pinto MI; Simão-Gurge RM; de Mello Almada Mimica AF; Goulart AL; dos Santos AM
    Vaccine; 2012 Oct; 30(46):6521-6. PubMed ID: 22959983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral responses to tetanus vaccination in Gabonese children.
    van Riet E; Retra K; Adegnika AA; Jol-van der Zijde CM; Uh HW; Lell B; Issifou S; Kremsner PG; Yazdanbakhsh M; van Tol MJ; Hartgers FC
    Vaccine; 2008 Jul; 26(29-30):3690-5. PubMed ID: 18539369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
    Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
    J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective anti-tetanus antibody responses of zoo-based Asian elephants (Elephas maximus) and rhinoceros (Rhinocerotidae).
    Muir YSS; Bryant B; Campbell-Ward M; Higgins DP
    Dev Comp Immunol; 2021 Jan; 114():103841. PubMed ID: 32861731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep.
    Chen D; Colditz IG; Glenn GM; Tsonis CG
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):177-82. PubMed ID: 12007883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.